February 21, 2017 | Patti Wieser
Kyle Nakanishi as the new Director of Business Operations
The Altman Clinical and Translational Research Institute (ACTRI) welcomes Kyle Nakanishi as the new Director of Business Operations. Kyle brings a wealth of knowledge in finance, business operations, departmental funds administration and contracts and grants. He joined ACTRI in December.
“Kyle has tremendous institutional experience in research program administration and strong relationships across the School of Medicine. We are delighted he has brought his talents to ACTRI,” said Eric Mah, Assistant Dean for Clinical and Translational Research.
As the Director of Business Operations, Kyle serves as the key administrative leader of ACTRI and is responsible for the day-to-day operations of the ACTRI, financial and budget oversight, research program administration and human resources.
Kyle began his career at UC San Diego in 2003 after receiving a bachelor’s degree from the university in the management of science. Prior to coming to ACTRI he served as assistant department business officer at the Department of Pediatrics, with earlier experience at the Scripps Institution of Oceanography, the Department of Chemistry and Biochemistry, and Mechanical and Aerospace Engineering. His career path has been textured by a primary pursuit. “My goal is to take the administrative burden from the scientists so they can concentrate on research,” he said. Kyle is comfortable in a research environment, having grown up in Livermore where his dad was a seismologist at the Livermore National Laboratory. But finance has always intrigued him. Research administration is a perfect fit.
His aims at ACTRI are to streamline financial systems, help the institute accomplish its goals outlined in the NIH Clinical and Translational Science Award (CTSA) grant, promote ACTRI services, and support staff development and teamwork. Kyle said he knew from the moment he came to UC San Diego that San Diego was where he wanted to live and the university was where he wanted to work. At ACTRI, he sees the direct impact of clinical research on lives, and enjoys playing a role in accelerating the discoveries that can improve human health. “Bench to bedside takes discoveries from the lab to the patient, and ACTRI plays a critical role in this translational process. I am happy to be part of it,” he said.
About UC San Diego Altman Clinical and Translational Research Institute:
UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,300 members.